Skip to main content
. 2017 Jun 30;8:696. doi: 10.3389/fimmu.2017.00696

Table 2.

Relative frequencies of detection of each immune factor in human milk within each population.

ETU (N = 40) GBR (N = 40) GBU (N = 40) GN (N = 40) KE (N = 42) PE (N = 43) SP (N = 41) SW (N = 24) USC (N = 19) USW (N = 41) p-Value*
IL1β 73a 83a 70a 98a 98a 72a 56ab 58ab 84a 24b <0.001
IL6 35ab 75a 50ab 33ab 69a 42ab 41ab 33ab 47ab 19b <0.001
IL12 13a 68bc 30ab 75c 24a 74c 17a 13a 10a 0a <0.001
INFγ 25ab 40a 18ab 18ab 26ab 26ab 2b 8ab 10ab 0b <0.001
TNFα 100a 83ab 30c 85ab 62abc 39bc 44bc 67abc 79abc 76abc <0.001
IL2 0 0 0 18 0 0 0 0 0 0
IL4 33a 23ab 0bc 33a 14abc 7bc 2bc 0c 5bc 0c <0.001
IL10 63a 98a 95a 90a 100a 79a 78a 0b 0b 0b <0.001
IL13 100a 68ab 45b 68ab 67ab 86ab 83ab 50b 53ab 66b <0.001
IL17 10 15 8 18 21 9 5 0 5 0 0.022
IL5 43abd 65bd 0c 15ac 60bd 5c 7ac 8ac 0c 0c <0.001
IL7 100a 100a 93a 73b 100a 100a 93a 100a 100a 100a <0.001
IgA 100 100 100 100 100 100 100 100 100 100 1
IgM 100 100 100 100 100 98 100 96 100 100 1
IgG 100 100 100 100 100 98 100 96 100 100 1
TGFβ2 100 100 100 100 100 100 100 96 100 100 0.114
IL8 100a 100a 100a 100a 100a 100a 100a 100a 100a 90b <0.001
GROα 100a 100a 100a 80b 100a 100a 100a 100a 100a 88ab <0.001
MCP1 85ab 85ab 83ab 95a 90ab 65ab 78ab 46bc 58abc 17c <0.001
MIP1β 100a 100a 98a 98a 100a 98a 95a 92a 95a 51b <0.001
GCSF 93a 73a 25bc 98a 90a 79a 71a 50abc 63ab 10c <0.001
GMCSF 10a 3a 5a 50b 5a 5a 7a 0a 0a 0a <0.001
EGF 100 100 100 100 100 100 100 100 100 100 1

ETU, urban Ethiopia; GBR, rural Gambia; GBU, urban Gambia; GN, Ghana; KE, Kenya; PE, Peru; SP, Spain; SW, Sweden; USC, USA/California; USW, USA/Washington; EGF, epidermal growth factor; GCSF, granulocyte colony-stimulating factor; GMCSF, granulocyte–macrophage colony-stimulating factor.

*Kruskal–Wallis test. Different caption letters mean statistical differences when the post hoc pairwise comparison Nemenyi test was done.

HHS Vulnerability Disclosure